We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.
Pharmaceuticals
LINHARDT ACQUIRES THREE PRODUCTION LINES FOR ALUMINUM TUBES PRODUCTION FROM NUSSBAUM
2021-11-26
Since July 2021, the management of LINHARDT and Nussbaum have been in intensive and bilateral discussions about LINHARDT's intention to acquire Nussbaum's aluminum tube business at its Swiss site in Kesswil.
We are very pleased to inform you that LINHARDT GmbH & Co. KG has acquired all three aluminum tube production lines as well as the customer base and order volume from Nussbaum Matzingen AG under an Asset Purchase Agreement (APA) effective October 31, 2021.
By the end of 2021, LINHARDT and Nussbaum will hold discussions with all customers with the aim of ensuring a smooth transition of orders.
Nussbaum will continue to produce at its Kesswill site until the end of Q1/ 2022 at the latest, so that the dismantling of the production lines will be carried out by LINHARDT at the beginning of Q2/ 2022. Production on these lines at LINHARDT's German sites in Viechtach and Pausa is expected to commence from Q4/2022, following corresponding supplementary investments to be made, although LINHARDT can also produce at its existing production facilities at an earlier desired date.
With this acquisition, says LINHARDT CEO Johannes Schick, "LINHARDT will significantly strengthen its market position in the Pharmaceutical Alumiunium Tubes business unit."
With this sale to LINHARDT, we are convinced that our customers will be in very good hands in the future, so that a smooth and high-quality supply will be ensured, according to the owner and CEO of Nussbaum, Florian J. Nussbaum.